Group 1 - The core point of the article is that Haijia Medical has been actively repurchasing its shares, with a total of 11 buybacks this year, amounting to 3.2734 million shares and a total expenditure of 42.2829 million HKD [2][3] - On December 30, the company repurchased 334,600 shares at a price range of 12.390 to 12.530 HKD, totaling 4.1648 million HKD, while the stock closed at 12.480 HKD, down 0.56% for the day [2] - Since December 29, the company has conducted buybacks for two consecutive days, repurchasing a total of 570,600 shares for a cumulative amount of 7.1624 million HKD, during which the stock price has decreased by 1.73% [2] Group 2 - The detailed buyback information shows that on December 29, 2025, the company repurchased 236,000 shares at a maximum price of 12.750 HKD and a minimum price of 12.540 HKD, totaling 2.9976 million HKD [3] - The buyback activities include various dates with different volumes and prices, indicating a strategic approach to managing share value [3] - The highest buyback price recorded this year was 14.140 HKD on January 2, 2025, while the lowest was 12.040 HKD on December 17, 2025 [3]
海吉亚医疗(06078.HK)12月30日回购33.46万股，耗资416.48万港元